Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Healthy Obese Phenotype Is a Myth

By HospiMedica International staff writers
Posted on 18 Jan 2015
A new study shows that even healthy obese adults tend to become unhealthy in the long-term, providing further evidence against the idea of healthy obesity.

Researchers at University College London (UCL; United Kingdom) conducted a study to answer a fundamental question: do healthy obese adults maintain this metabolically healthy profile over the long term, or do they naturally suffer transition into unhealthy obesity over time. More...
To do so, they followed 2,521 British government workers (75% male, ages 39–62 years at baseline), of whom more than 180 were obese, with 66 (36.5%) of them classified as healthy obese.

At 5, 10, 15, and 20 years follow-up, 21, 27, 23, and 34 of these individuals remained obese, but had a worsening of their cardiometabolic profile, resulting in more than 51% of previously healthy obese participants deemed unhealthy obese at the 20-year mark. Just six percent of people in the healthy obese group lost weight, and were reclassified as healthy non-obese at the end of the first five years. This percentage rose to 10.6% at 20 years. The study was published in the January 6, 2015, issue of the Journal of the American College of Cardiology.

“Healthy obese adults were nearly eight times more likely to progress to an unhealthy obese state after 20 years than healthy non-obese adults, providing further evidence against the idea that obesity can be healthy,” concluded lead study author Joshua Bell, MSc, and colleagues. “Healthy obesity is only healthy in a relative sense, in that the risk of disease is lower than for unhealthy obese adults, but still higher than for healthy normal-weight adults.”
For the study, metabolically healthy was defined as having less than two of the following risk factors: HDL cholesterol lower than 1.03 mmol/L for men and lower than 1.29 mmol/L for women; blood-pressure higher than 130/85 mmHg or use of antihypertensive medications; fasting plasma glucose levels of over 5.6 mmol/L or use of antidiabetic medications; triglyceride level higher than 1.7 mmol/L; and a homeostatic model assessment (HOMA) of insulin resistance higher than 2.87.

Related Links:

University College London



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.